Spinal cord injury (SCI) disrupts neural circuitry through acute mechanical trauma followed by secondary degeneration—inflammation, ischaemia, apoptosis—that extends the initial lesion zone over hours to days.
Spinal cord injury (SCI) disrupts neural circuitry through acute mechanical trauma followed by secondary degeneration—inflammation, ischaemia, apoptosis—that extends the initial lesion zone over hours to days. Neurogenic stem cells and neural progenitor cells derived from umbilical cord or fetal sources can differentiate into oligodendrocytes (restoring myelin) and astrocytes (stabilising the lesion core), whilst also secreting neurotrophic factors (BDNF, NGF, NT-3) that promote axonal plasticity and regeneration. Placental mesenchymal stem cells provide complementary neuroprotection and angiogenesis. Sixty-nine registered trials and eight actively recruiting centres explore cell transplantation, often combined with rehabilitation, in both acute (<2 weeks) and chronic (>6 months) SCI populations.
| 指示性成本 · 保加利亚 (EU) | €3,000–€8,000 |
|---|---|
| 全球市场成本范围 | €23,000–€36,800 (cellmedicine.com) |
| 研究的主要细胞类型 | Neurogenic Cells, MSCs from Amniotic Membrane, Exosomes |
| 批准状态 | 研究性 |
| 注册的临床试验 (ClinicalTrials.gov) | 69 · 8 recruiting now |
For the clinic's own description, see our partner clinic Stem Plus.
Clinical trial data spans phase I safety (no serious adverse events in >300 recipients) through phase II efficacy assessment. Representative studies in chronic SCI (>1 year post-injury) report motor score improvements (ASIA scale) of 2–6 points in 35–50% of treated cohorts over 12 months, with some sensory recovery (pin-prick, light-touch perception restoration) in 20–30%. Neuroimaging (DTI, fMRI) shows increased white-matter fractional anisotropy and expanded motor-cortex activation maps in responders. Acute-phase trials show more variable outcomes; lesion cavity volume reduction has been documented but functional translation remains uncertain.
Depending on assessment, a Spinal Cord Injury protocol may draw on:
SCI stem-cell protocols in Sofia and international centres range €8,000–12,000 for comprehensive treatment, incorporating 1–3 intraspinal cell injections (requiring neurosurgical expertise and operative suite time), baseline and serial neuroimaging (MRI, CT), neuroelectrophysiological testing (EMG, evoked potentials), and intensive post-operative rehabilitation (3–6 months). Neurosurgical consultation, anaesthesia, and inpatient recovery add to facility costs. Travel and accommodation for international patients constitute substantial additional burden.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Spinal Cord Injury cost-by-country breakdown, or compare the best countries for Spinal Cord Injury →
Before booking, check safety & regulation, the recovery climate, 您是否可能是候选人, and which cell type fits Spinal Cord Injury.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: 我是候选人吗？ · 哪种细胞类型？ · Types of clinics & best countries · 成本计算器
由 StemCellAtlas 的编辑团队进行医学审查，与Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估